Wearable Sensor Can Monitor Sleep Apnea Treatment Response
By Lori Solomon HealthDay Reporter
MONDAY, May 19, 2025 -- A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases, according to a study presented at the American Thoracic Society 2025 International Conference, held from May 18 to 21 in San Francisco.
Ketan Mehta, from Apnimed Inc. in Cambridge, Massachusetts, and colleagues developed a connected wearable software platform for use with a wearable proximal finger-mounted pulse oximeter to enable serial overnight recordings of saturation of peripheral oxygen and pulse rate (transmittance-based photoplethysmography) and motion (three-axis accelerometer). The platform was tested in 104 patients with OSA (2,017 overnight recordings) as part of ongoing trials.
The researchers report that the device was used in several different clinical settings, including to monitor patient response to a pharmacologic treatment program for OSA. As part of the study, patients were asked to wear the device for nine nights during a 47-day period, but 85 percent of patients used the device beyond the recommended nights.
"These data empower both parties to be informed, and they're able to have more meaningful conversations," Mehta said in a statement. "This offers the opportunity for shared decision-making between patient and provider using digital medicine."
The study was funded by Apnimed.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 -- In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...
Risk for Death, MACE Increased for Patients With Adult-Onset Type 1 Diabetes
FRIDAY, May 16, 2025 -- Adult-onset type 1 diabetes (T1D) is associated with an increased risk for death and major adverse cardiovascular events (MACE), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.